Loading stock data…
SHPH
$0.45-0.03 (-6.55%)
After Hours$0.44-0.01 (-1.99%)· Last close Jun 9
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Shuttle Pharmaceuticals Holdings, Inc. in the Healthcare sector is trading at $0.45 with a market capitalization of $3M. The stock is currently near its 52-week low of $0.38, remaining 76.3% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 26) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$0.45
Potential Downside
80.9%
Whystock Fair Value$0.09
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug de...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.07M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
52.40
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.41
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-323.38%
Volume
Today's trading volume
516,620
Recent News
Shuttle to Acquire United Dogecoin in Push to Build Public DOGE Mining Platform
Shuttle Pharmaceuticals Holdings (NASDAQ: $SHPH) said it has signed a definitive merger agreement to acquire United...
Shuttle Pharma Layers AI Into Its Big Oncology Push
This pharma name is betting AI can shave time, cost, and guesswork out of cancer drug development [Sponsored Post]
Shuttle Pharmaceuticals says reverse stock split to become effective June 16
Shuttle Pharmaceuticals (SHPH) announced that the reverse stock split will become effective on June 16, at 12:01 a.m., Eastern Time. The company’s common stock will continue to trade on The Nasdaq Capital Market under the existing symbol “SHPH” and will begin trading on a split-adjusted basis when the market opens on June 16. At the effective time of the reverse stock split, every 25 shares of the company’s issued and outstanding common stock will be automatically reclassified and combined into